Back to Journals » Infection and Drug Resistance » Volume 16

Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report [Corrigendum]

Authors Chen P , An L, Zhang Z

Received 24 March 2023

Accepted for publication 24 March 2023

Published 27 March 2023 Volume 2023:16 Pages 1751—1752

DOI https://doi.org/10.2147/IDR.S414041



Chen P, An L, Zhang Z. Infect Drug Resist. 2023;16:1573–1578.

Page 1575, paragraph two, line 10, the text “(600 mg IV q12d)” should read “(600 mg IV q12h)”.

Page 1575, paragraph two, line 12, the text “(400 mg PO q12d)” should read “(400 mg PO q12h)”.

Page 1576, paragraph five, line three, the text “contezolid 400 mg q12d” should read “contezolid 400 mg q12h”.

Page 1576, paragraph five, line six, the text “recommended dose of 800 mg q12d” should read “recommended dose of 800 mg q12h”.

The authors apologize for these errors and any confusion it may have caused the reader.


Read the original article


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.